Shepard Jay - Insider Non-Derivative Transactions at Esperion Therapeutics, Inc. (ESPR) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on May 23, 2024, Shepard Jay's relationship to Esperion Therapeutics, Inc. (ESPR) is Director, and currently has 51,599 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other ESPR insiders.
Data Source: SEC.
Shepard Jay - Insider Non-Derivative Transactions of ESPR Common Stock
Shepard Jay - Insider Non-Derivative Transactions at ESPR
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| May 24, 2024 | Acquisition -- (Common Stock) | 23000 | 0 | 51599 |
| Jun 16, 2023 | Acquisition -- (Common Stock) | 5150 | 0 | 28599 |